SRG Holding Group is a family-owned investment office based in Dubai and chaired by Mohamed AlRafi. The company traces its origins to 1958, when Mohamed's late father, Abdulsalam AlRafi, established a commodities trading business in the Al Ras souq in Deira that later evolved into a real estate enterprise. Today, under the leadership of Mohamed and his brother, Fahad AlRafi, the company's CEO, SRG has grown into a multibillion-dollar investment platform with a portfolio of premier residential, commercial, and hospitality assets, serving as a landowner, developer, operator, asset manager, leasing and sales specialist, and facilities management provider.

​

Within the United Arab Emirates, the Group’s portfolio comprises a number of landmark assets, including Burj Al Salam, Marina Heights Tower, Marquise Square Tower, Upside Living, Aria Gardens, Al Salam Tecom Tower, Palacio Tower, and Grove Mall, in addition to the upcoming SRG Tower, among others. The group also owns and operates a growing hospitality portfolio under long-term franchise agreements with leading international hotel brands, including Marriott International through Sheraton Grand Dubai and IHG Hotels & Resorts through Staybridge Suites Dubai Financial Centre and Staybridge Suites Dubai Internet City, with forthcoming VOCO-branded hotels near the Mall of the Emirates.

​

SRG Holding's portfolio extends to the UK, with High Holborn Estate, a freehold island site in London's Midtown, encompassing nine buildings and 150,000 square feet of commercial space. The wider London portfolio includes 202 Hammersmith Road in west London, home to Victoria Beckham's global headquarters; a mixed-use office and retail space in Westbourne Grove, comprising nearly 13,000 square feet; and Castanea Court on Coombe Road in New Malden, southeast London, a 1.1-acre site consisting of a residential and retail development, alongside further development sites in south and southeast London on Streatham High Road and in Grove Park, Lewisham.  Additionally, SRG Holding holds private equity investments across Europe and the United States, spanning real estate, biomedical technology, and medical devices.

​